Globus Medical, Inc.
GMED · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $769,048 | $745,342 | $598,121 | $657,293 |
| % Growth | 3.2% | 24.6% | -9% | – |
| Cost of Goods Sold | $282,376 | $248,765 | $195,397 | $263,437 |
| Gross Profit | $486,672 | $496,577 | $402,724 | $393,856 |
| % Margin | 63.3% | 66.6% | 67.3% | 59.9% |
| R&D Expenses | $38,067 | $39,954 | $33,062 | $33,408 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $313,597 | $303,622 | $242,799 | $253,481 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $76,892 | $29,859 | $46,693 |
| Operating Expenses | $351,664 | $420,468 | $305,720 | $333,582 |
| Operating Income | $135,008 | $76,109 | $97,004 | $60,274 |
| % Margin | 17.6% | 10.2% | 16.2% | 9.2% |
| Other Income/Exp. Net | $8,986 | $112,064 | $6,664 | -$35,607 |
| Pre-Tax Income | $143,994 | $188,173 | $103,668 | $24,667 |
| Tax Expense | $25,028 | -$14,673 | $28,206 | -$1,838 |
| Net Income | $118,966 | $202,846 | $75,462 | $26,505 |
| % Margin | 15.5% | 27.2% | 12.6% | 4% |
| EPS | 0.88 | 1.5 | 0.55 | 0.19 |
| % Growth | -41.3% | 172.7% | 189.5% | – |
| EPS Diluted | 0.88 | 1.49 | 0.54 | 0.19 |
| Weighted Avg Shares Out | 134,502 | 135,205 | 136,757 | 136,729 |
| Weighted Avg Shares Out Dil | 135,394 | 136,499 | 139,774 | 139,711 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,455 | $693 | $1,681 | $0 |
| Interest Expense | $0 | $0 | $0 | $815 |
| Depreciation & Amortization | $71,126 | $70,631 | $66,074 | $68,228 |
| EBITDA | $215,120 | $193,443 | $164,135 | $145,283 |
| % Margin | 28% | 26% | 27.4% | 22.1% |